Lymphoma Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global lymphoma treatment market size reached US$ 12.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 20.1 Billion by 2028, exhibiting a growth rate (CAGR) of 8.7% during 2022-2028.
Lymphoma refers to a type of cancer characterized by the rapid development of abnormal malignant cells in the lymphatic system. It usually targets the white blood cells (WBCs), or lymphocytes, in lymph nodes, spleen, thymus and bone marrow and impairs the immune response of the body. As a result, the patient develops swelling in the lymph nodes, high fever, weight loss, dyspnea and fatigue. Some of the commonly used lymphoma therapeutics include radiation, chemo and monoclonal antibody therapy, active surveillance, bone marrow transplant and immunotherapy drugs. These therapeutics are widely used for the treatment of both Hodgkin and non-Hodgkin lymphoma.
The increasing prevalence of non-Hodgkin lymphoma across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. In line with this, the increasing awareness among the masses regarding the available diagnostic technologies and treatment alternatives for lymphoma is also creating a positive outlook for the market. Hospitals and other diagnostic centers are using innovative tests and imaging technologies, such as computed tomography (CT), Magnetic Resonance Imaging (MRI) and positron emission tomography (PET) scans, for accurate identification of the cancer cells and timely treatment. Additionally, various technological advancements, including the development of innovative immune checkpoint inhibitors, which block proteins from binding together and increase the response strength of T-cells against cancer cells, are contributing to the market growth. Other factors, including extensive research and development (R&D) activities in the field of oncology, along with overall improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global lymphoma treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, test type and drug.
Breakup by Type:
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Breakup by Test Type:
Chemotherapy
Radiation Therapy
Immunotherapy
Targeted Therapy
Biologic Therapy
Others
Breakup by Drug:
Adcetris
Rituxan
Opdivo
Imbruvica
Keytruda
Revlimid
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis International AG, Spectrum Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
How has the global lymphoma treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global lymphoma treatment market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the drug?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global lymphoma treatment market and who are the key players?
What is the degree of competition in the industry?
Lymphoma refers to a type of cancer characterized by the rapid development of abnormal malignant cells in the lymphatic system. It usually targets the white blood cells (WBCs), or lymphocytes, in lymph nodes, spleen, thymus and bone marrow and impairs the immune response of the body. As a result, the patient develops swelling in the lymph nodes, high fever, weight loss, dyspnea and fatigue. Some of the commonly used lymphoma therapeutics include radiation, chemo and monoclonal antibody therapy, active surveillance, bone marrow transplant and immunotherapy drugs. These therapeutics are widely used for the treatment of both Hodgkin and non-Hodgkin lymphoma.
The increasing prevalence of non-Hodgkin lymphoma across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. In line with this, the increasing awareness among the masses regarding the available diagnostic technologies and treatment alternatives for lymphoma is also creating a positive outlook for the market. Hospitals and other diagnostic centers are using innovative tests and imaging technologies, such as computed tomography (CT), Magnetic Resonance Imaging (MRI) and positron emission tomography (PET) scans, for accurate identification of the cancer cells and timely treatment. Additionally, various technological advancements, including the development of innovative immune checkpoint inhibitors, which block proteins from binding together and increase the response strength of T-cells against cancer cells, are contributing to the market growth. Other factors, including extensive research and development (R&D) activities in the field of oncology, along with overall improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global lymphoma treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, test type and drug.
Breakup by Type:
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Breakup by Test Type:
Chemotherapy
Radiation Therapy
Immunotherapy
Targeted Therapy
Biologic Therapy
Others
Breakup by Drug:
Adcetris
Rituxan
Opdivo
Imbruvica
Keytruda
Revlimid
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis International AG, Spectrum Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
How has the global lymphoma treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global lymphoma treatment market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the drug?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global lymphoma treatment market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL LYMPHOMA TREATMENT MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Hodgkin Lymphoma
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Non-Hodgkin Lymphoma
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TEST TYPE
7.1 Chemotherapy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Radiation Therapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Immunotherapy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Targeted Therapy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Biologic Therapy
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY DRUG
8.1 Adcetris
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Rituxan
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Opdivo
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Imbruvica
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Keytruda
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Revlimid
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bristol-Myers Squibb Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Eli Lilly and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 F. Hoffmann-La Roche Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Johnson & Johnson Services, Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis International AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Spectrum Pharmaceuticals, Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Takeda Pharmaceutical Company Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Teva Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL LYMPHOMA TREATMENT MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Hodgkin Lymphoma
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Non-Hodgkin Lymphoma
6.2.1 Market Trends
6.2.2 Market Forecast
7 MARKET BREAKUP BY TEST TYPE
7.1 Chemotherapy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Radiation Therapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Immunotherapy
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Targeted Therapy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Biologic Therapy
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY DRUG
8.1 Adcetris
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Rituxan
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Opdivo
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Imbruvica
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Keytruda
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Revlimid
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Others
8.7.1 Market Trends
8.7.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bristol-Myers Squibb Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Eli Lilly and Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 F. Hoffmann-La Roche Ltd.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Johnson & Johnson Services, Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis International AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Spectrum Pharmaceuticals, Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Takeda Pharmaceutical Company Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Teva Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Lymphoma Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Lymphoma Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Lymphoma Treatment Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 4: Global: Lymphoma Treatment Market Forecast: Breakup by Drug (in Million US$), 2023-2028
Table 5: Global: Lymphoma Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Lymphoma Treatment Market: Competitive Structure
Table 7: Global: Lymphoma Treatment Market: Key Players
Table 1: Global: Lymphoma Treatment Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Lymphoma Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Lymphoma Treatment Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 4: Global: Lymphoma Treatment Market Forecast: Breakup by Drug (in Million US$), 2023-2028
Table 5: Global: Lymphoma Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Lymphoma Treatment Market: Competitive Structure
Table 7: Global: Lymphoma Treatment Market: Key Players
LIST OF FIGURES
Figure 1: Global: Lymphoma Treatment Market: Major Drivers and Challenges
Figure 2: Global: Lymphoma Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Lymphoma Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Lymphoma Treatment Market: Breakup by Type (in %), 2022
Figure 5: Global: Lymphoma Treatment Market: Breakup by Test Type (in %), 2022
Figure 6: Global: Lymphoma Treatment Market: Breakup by Drug (in %), 2022
Figure 7: Global: Lymphoma Treatment Market: Breakup by Region (in %), 2022
Figure 8: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Lymphoma Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Lymphoma Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Lymphoma Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Lymphoma Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Lymphoma Treatment (Immunotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Lymphoma Treatment (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Lymphoma Treatment (Targeted Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Lymphoma Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Lymphoma Treatment (Biologic Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Lymphoma Treatment (Biologic Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Lymphoma Treatment (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Lymphoma Treatment (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Lymphoma Treatment (Adcetris) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Lymphoma Treatment (Adcetris) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Lymphoma Treatment (Rituxan) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Lymphoma Treatment (Rituxan) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Lymphoma Treatment (Opdivo) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Lymphoma Treatment (Opdivo) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Lymphoma Treatment (Imbruvica) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Lymphoma Treatment (Imbruvica) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Lymphoma Treatment (Keytruda) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Lymphoma Treatment (Keytruda) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Lymphoma Treatment (Revlimid) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Lymphoma Treatment (Revlimid) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Lymphoma Treatment (Other Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Lymphoma Treatment (Other Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: North America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: United States: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: United States: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Canada: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Canada: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Asia-Pacific: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Asia-Pacific: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: China: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: China: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Japan: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Japan: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: India: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: India: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: South Korea: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: South Korea: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Australia: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Australia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Indonesia: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Indonesia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Europe: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Europe: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Germany: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Germany: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: France: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: France: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: United Kingdom: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: United Kingdom: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Italy: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Italy: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Spain: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Spain: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Russia: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Russia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Latin America: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Latin America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Brazil: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Brazil: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Mexico: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Mexico: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Middle East and Africa: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Middle East and Africa: Lymphoma Treatment Market: Breakup by Country (in %), 2022
Figure 86: Middle East and Africa: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Global: Lymphoma Treatment Industry: SWOT Analysis
Figure 88: Global: Lymphoma Treatment Industry: Value Chain Analysis
Figure 89: Global: Lymphoma Treatment Industry: Porter's Five Forces Analysis
Figure 1: Global: Lymphoma Treatment Market: Major Drivers and Challenges
Figure 2: Global: Lymphoma Treatment Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Lymphoma Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Lymphoma Treatment Market: Breakup by Type (in %), 2022
Figure 5: Global: Lymphoma Treatment Market: Breakup by Test Type (in %), 2022
Figure 6: Global: Lymphoma Treatment Market: Breakup by Drug (in %), 2022
Figure 7: Global: Lymphoma Treatment Market: Breakup by Region (in %), 2022
Figure 8: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Lymphoma Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Lymphoma Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Lymphoma Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Lymphoma Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Lymphoma Treatment (Immunotherapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Lymphoma Treatment (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Lymphoma Treatment (Targeted Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Lymphoma Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Lymphoma Treatment (Biologic Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Lymphoma Treatment (Biologic Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Lymphoma Treatment (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Lymphoma Treatment (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Lymphoma Treatment (Adcetris) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Lymphoma Treatment (Adcetris) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Lymphoma Treatment (Rituxan) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Lymphoma Treatment (Rituxan) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Lymphoma Treatment (Opdivo) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Lymphoma Treatment (Opdivo) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Lymphoma Treatment (Imbruvica) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Lymphoma Treatment (Imbruvica) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Lymphoma Treatment (Keytruda) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Lymphoma Treatment (Keytruda) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Lymphoma Treatment (Revlimid) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Lymphoma Treatment (Revlimid) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Lymphoma Treatment (Other Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Lymphoma Treatment (Other Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: North America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: United States: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: United States: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Canada: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Canada: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Asia-Pacific: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Asia-Pacific: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: China: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: China: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Japan: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Japan: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: India: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: India: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: South Korea: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: South Korea: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Australia: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Australia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Indonesia: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Indonesia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Europe: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Europe: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Germany: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Germany: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: France: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: France: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: United Kingdom: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: United Kingdom: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Italy: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Italy: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Spain: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Spain: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Russia: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Russia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Latin America: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Latin America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Brazil: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Brazil: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Mexico: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Mexico: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Middle East and Africa: Lymphoma Treatment Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Middle East and Africa: Lymphoma Treatment Market: Breakup by Country (in %), 2022
Figure 86: Middle East and Africa: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Global: Lymphoma Treatment Industry: SWOT Analysis
Figure 88: Global: Lymphoma Treatment Industry: Value Chain Analysis
Figure 89: Global: Lymphoma Treatment Industry: Porter's Five Forces Analysis
